Inter-organ crosstalk in health and cardiovascular-renal-hepatic-metabolic disease: A multidisciplinary perspective
- 25 October 2025
- journal article
- Published by Elsevier in Metabolism
- Vol. 174, 156424
Abstract
No abstract availableFunding Information
- National Heart, Lung, and Blood Institute (R01 HL172875)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK124329)
This publication has 41 references indexed in Scilit:
- Noninvasive Hepatic Steatosis and Fibrosis Indices Differentially Predict Mortality in the Adult Korean PopulationClinical Gastroenterology and Hepatology, 2024
- GDF-15 improves the predictive capacity of steatotic liver disease non-invasive tests for incident morbidity and mortality risk for cardio-renal-metabolic diseases and malignanciesMetabolism, 2024
- Management of patients with the cardio renal liver metabolic syndrome: The need for a multidisciplinary approach in research, education and practiceMetabolism, 2024
- DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseasesMetabolism, 2024
- Obesity and diabetesDiabetes Research and Clinical Practice, 2023
- Recent guidelines for Non-Alcoholic Fatty Liver disease (NAFLD)/ Fatty Liver Disease (FLD): Are they already outdated and in need of supplementation?Metabolism, 2022
- Depletion of dendritic cells in perivascular adipose tissue improves arterial relaxation responses in type 2 diabetic miceMetabolism, 2018
- The “thrifty” gene encoding Ahsg/Fetuin-A meets the insulin receptor: Insights into the mechanism of insulin resistanceCellular Signalling, 2011
- Leptin ResistanceJACC, 2008
- Myostatin, a transforming growth factor-? superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarctJournal of Cellular Physiology, 1999